IP Library Granted Patent US 10,934,309
Granted Patent B2
US 10,934,309 · App. 16/233,816 · Granted Mar 2, 2021

Tricyclic quinone derivative

Inventors: Hitoshi Ban (Osaka, JP); Seiji Kamioka (Osaka, JP); Shoukou Ri (Osaka, JP); Tomoyuki Furuta (Osaka, JP); Hiroyuki Kitano (Osaka, JP); Chiang Jia Li (Cambridge, MA)
Assignee: Sumitomo Dainippon Pharma Oncology, Inc.
C07D495/04A61K31/381A61K31/4355A61K31/4365A61K31/5377C07D471/04C07D491/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,309
App. No.
16/233,816
Granted
Mar 2, 2021
Kind
B2
Abstract

This invention provides a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides a compound represented by formula (1) or a pharmaceutically acceptable salt thereof [Therein, A is O, S, or N—R 6 ; ring G is a 5-membered or 6-membered aromatic ring, etc., including 1-3 heteroatoms selected from O, S and N as constituent atoms; R 1 and R 2 are each independently a hydrogen atom, a halogen atom, or an optionally-substituted C 1-6 alkyl carbonyl group, etc.; R 3 , R 4 and R 5 are each independently a hydrogen atom, a halogen atom, or an optionally-substituted C 1-6 alkyl carbonyl group, etc.; and R 6 is a hydrogen atom or an optionally-substituted C 1-6 alkyl group, etc.].

Claims (78)

1. A compound or a pharmacologically acceptable salt thereof, wherein the compound is selected from the group consisting of:

Example

Name

Structure

1

2-acetylthieno[2,3-g]quinoline-4,9-dione

2

2-(1-hydroxyethyl)thieno[2,3-g]quinoline-4,9- dione

3

N,N-dimethyl-4,9-dioxo-4,9-dihydrothieno[2,3- g]quinoline-2-carboxamide

4

2-(morpholin-4-ylmethyl)thieno[2,3-g]quinoline- 4,9-dione

5

2-{[cyclohexyl(ethyl)amino]methyl}thieno[2,3- g]quinoline-4,9-dione

6

2-{[ethyl(2- methoxyethyl)amino]methyl}thieno[2,3 g]quinoline-4,9-dione

7

2-{[ethyl(pyridin-4- ylmethyl)amino]methyl}thieno[2,3-g]quinoline- 4,9-dione

8

2-(((4,9-dioxo-4,9-dihydrothieno[2,3-g]quinolin- 2-yl)methyl)(ethyl)amino)-N,N- dimethylacetamide

12

2-acetylthieno[2,3-g]isoquinoline-4,9-dione

13

2-(1-hydroxyethyl)thieno[2,3-g]isoquinoline-4,9- dione

14

2-(1-hydroxymethyl)thieno[2,3-g]isoquinoline- 4,9-dione

15

2-(2-hydroxypropan-2-yl)thieno[2,3- g]isoquinoline-4,9-dione

16

2-[cyclopropyl(hydroxy)methyl]thieno[2,3- g]isoquinoline-4,9-dione

17

2-[cyclopropl(ethoxy)methyl]thieno[2,3- g]isoquinoline-4,9-dione

18

2-[(benzyloxy)methyl]thieno[2,3-g]isoquinoline- 4,9-dione

19

N,N-dimethyl-4,9-dioxo-4,9-dihydrothieno[2,3- g]isoquinoline-2-carboxamide

20

2-(morpholin-4-ylcarbonyl)thieno[2,3- g]isoquinoline-4,9-dione

21

N-(2,2-difluoroethyl)-4,9-dioxo-4,9- dihydrothieno[2,3-g]isoquinoline-2-carboxamide

23

2-[1-(morpholin-4-yl)ethyl]thieno[2,3- g]isoquinoline-4,9-dione

24

2-{[ethyl(2- methoxyethyl)amino]methyl}thieno[2,3- g]isoquinoline-4,9-dione

25

2-((cyclohexyl(ethyl)amino)methyl)thieno[2,3- g]isoquinoline-4,9-dione

26

2-{[(2,2-difluorocthyl)amino]methyl}thieno[2,3- g]isoquinoline-4,9-dione

27

2-[(4-acetylpiperazin-1-yl)methyl]thieno[2,3- g]isoquinoline-4,9-dione

28

N-(2,2-difloroethyl)-N-((4,9-dioxo-4,9- dihydrothieno[2,3-g]isoquinolin-2- yl)methyl)cyclohexanecarboxamide

29

4,9-dioxo-4,9-dihydrothieno[2,3-g]isoquinoline- 2-carbonitrile

30

2-(1-fluoroethyl)thieno[2,3-g]isoquinoline-4,9- dione

31

2-(3-ethyl-1,2,4-oxadiazol-5-yl)thieno[2,3- g]isoquinoline-4,9-dione

32

2-(morpholin-4-yl)thieno[2,3-g]isoquinoline-4,9- dione

33

2-acetylthieno[3,2-g]isoquinoline-4,9-dione

36

2-acetylthieno[3,2-g]quinoline-4,9-dione

37

2-(1-hydroxyethyl)thieno[3,2-g]quinoline-4,9- dione

38

2-(1-methoxyethyl)thieno[3,2-g]quinoline-4,9- dione

39

2-(3,5-dimethylpiperidine-1-carbonyl)thieno[3,2- g]quinoline-4,9-dione

40

N-(2,2-difluorocthyl)-4,9-dioxo-4,9- dihydrothieno[3,2-g]quinoline-2-carboxamide

41

tert-butyl (4,9-dioxo-4,9-dihydrothieno[3,2- g]quinolin-2-yl)(methyl)carbamate

60

ethyl (E)-3-(4,9-dioxo-4,9-dihydrothieno[2,3- g]isoquinolin-2-yl)acrylate

61

2-ethynylthieno[2,3-g]isoquinoline-4,9-dione

Assignments (1)
CHANGE OF NAME Recorded Sep 4, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053708/0635 →
Priority Claims (1)
JP 2014-072398 · Mar 31, 2014 · national
Continuity (3)
Continuation 16054875 · Aug 3, 2018
Continuation 15300917
Related Publication 20190241583A1 · Aug 8, 2019